Defibrillators Market by Product (Implantable Defibrillators, External Defibrillators), End-User (Hospitals, Prehospital, Public Access, Alternate Care, Home) - Global Opportunity Analysis and Industry Forecast, 2019 – 2030

"Market Definition:
The Global Defibrillator Market was valued at USD 10.27 billion in 2019 and is expected to garner USD 20.11 billion by 2030, expanding at a CAGR of 6.3%, during the forecast period, from 2020 to 2030.
Defibrillators are used to deliver therapeutic shocks to a patient’s heart in life threatening conditions such as cardiac arrhythmia, ventricular fibrillation and pulseless ventricular tachycardia. This device depolarizes the heart muscles by providing an electric shock and restore its normal function. Defibrillators helps in the prevention of untimely death due to the various heart conditions.
Market Dynamics and Trends
The expansion of the global defibrillators market is attributed to rapid developments in the healthcare infrastructure due to increasing awareness and technological advancements, rising focus of public & private organizations on public access defibrillators, and growing prevalence of cardiovascular disorders. Additionally, presence of large number of training & awareness programs, high demand for quality medical care, increasing geriatric population, rising incidences of Sudden Cardiac Arrests (SCA) and growing need for emergency services are expected to further boosts the market growth.
However, high cost of defibrillators and increase in the number of product recalls are expected to impede the market growth. On the other hand, rise in investment by market players for technological development is expected to create new opportunities for the defibrillators market.
Market Segmentations and Scope of the Study:
The global defibrillator market is segmented based on product, end user, and geography.

On the basis of product

, the market is bifurcated into implantable defibrillators and external defibrillators. The implantable defibrillators segment is segmented into Transvenous Implantable Cardioverter Defibrillator (T-ICD), Subcutaneous Implantable Cardioverter Defibrillator (S-ICD), and Cardiac Resynchronization Therapy- Defibrillator (CRT-D). The External Defibrillators segment is further sub-divided into Manual External Defibrillator (MED), Automated External Defibrillator (AED), and Wearable Cardioverter Defibrillator (WCD). In terms of end user, the market is categorized as hospitals, prehospital, public access, alternate care, and home. Based geography, the global defibrillator market is segregated into North America, Europe, Asia-Pacific, and Rest of World (RoW).
Geographical Analysis
North America accounts for a major share of the market owing to the presence of developed healthcare infrastructure, favourable reimbursement policies, high prevalence of cardiovascular disorders, and technological advancements.
The market in Asia Pacific is growing due to the developments in healthcare infrastructure and rising prevalence of cardiac arrest.

Competitive Landscape

Key players in the global defibrillator market include Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc. These players engage in product development, mergers & acquisitions, and regional expansion to increase their market penetration.
KEY MARKET SEGMENTS:
• Global Defibrillator Market – By Product
o Implantable Defibrillators
 Transvenous Implantable Cardioverter Defibrillator (T-ICD)
 Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
 Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
o External Defibrillators
 Manual External Defibrillator
 Automated External Defibrillator (AED),
 Wearable Cardioverter Defibrillator (WCD).
Global Defibrillator Market – End User
o Hospitals
o Prehospital
o Public Access
o Alternate Care
o Home
• Global Defibrillator Market – By Geography
o North America
 U.S.
 Canada
 Mexico
o Europe
 Germany
 U.K.
 France
 Italy
 Spain
 Rest of Europe
o Asia-Pacific
 Japan
 China
 India
 Australia
 Rest of Asia-Pacific
o RoW
 Brazil
 Argentina
 Egypt
 Israel
 South Africa
 Remaining Countries
KEY PLAYERS:
• Asahi Kasei Corporation
• Stryker Corporation
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Philips Healthcare
• LivaNova PLC
• Medtronic plc
• Cardiac Science Corporation
• Nihon Kohden Corporation
• St. Jude Medical, Inc."